Overview

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if vinflunine can shrink or slow the growth of the cancer or increase survival in patients with transitional cell carcinoma of the urothelium. The safety of this treatment will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb
Collaborator:
Pierre Fabre Medicament
Treatments:
Vinblastine